tiprankstipranks
Advertisement
Advertisement

Delorean Advances Flagship Bioenergy Projects Amid Policy Tailwinds in Renewable Gas

Story Highlights
  • Delorean progressed key bioenergy assets, completing Lilydale, advancing SA1 and VIC1, while pursuing alternatives for its NSW project.
  • New policy support and the Opal partnership reinforce Delorean’s positioning in Australia’s renewable gas and decarbonisation landscape.
  • Looking for the best stocks to buy? Follow the recommendations of top-performing analysts.
Delorean Advances Flagship Bioenergy Projects Amid Policy Tailwinds in Renewable Gas

Claim 55% Off TipRanks

An update from Delorean Corporation Ltd ( (AU:DEL) ) is now available.

Delorean Corporation ended the December 2025 quarter with a cash balance of $4.8 million and customer receipts of $1.8 million, while materially progressing its core bioenergy project pipeline. The company achieved practical completion of Yarra Valley Water’s $53 million Lilydale food-waste-to-energy facility and moved into an $8 million operations and maintenance phase, advanced construction of its flagship SA1 Salisbury Build-Own-Operate asset in Adelaide and secured the first $2.7 million milestone payment from ARENA, and continued to lock in long-term feedstock agreements. While Brickworks chose not to proceed to a final investment decision on the proposed NSW1 Horsley Park bioenergy plant, Delorean is pursuing alternative pathways to bring a New South Wales project to construction, continued development work on its VIC1 project toward an expected final investment decision in the second half of FY26, and signed a strategic MOU and master services agreement with Opal for an Opal-funded feasibility study at the Maryvale paper mill that could lead to further bioenergy developments nationally under its BOO model. These operational milestones and policy tailwinds — including the launch of the NSW Renewable Fuel Scheme and Renewable Fuels Strategy, which elevate renewable gas as a key decarbonisation tool — strengthen Delorean’s positioning in Australia’s emerging renewable gas market and support the long-term economics of its project pipeline for investors and stakeholders.

The most recent analyst rating on (AU:DEL) stock is a Sell with a A$0.08 price target. To see the full list of analyst forecasts on Delorean Corporation Ltd stock, see the AU:DEL Stock Forecast page.

More about Delorean Corporation Ltd

Delorean Corporation Limited is an Australian bioenergy and renewables company focused on developing, building, owning and operating anaerobic digestion and food-waste-to-energy facilities. Its projects target the production of renewable gas, including biomethane, to support decarbonisation across energy, industry and transport sectors in Australia, with a growing portfolio of Build-Own-Operate assets and partnerships with utilities and industrial partners.

Average Trading Volume: 167,810

Technical Sentiment Signal: Sell

Current Market Cap: A$21.15M

For an in-depth examination of DEL stock, go to TipRanks’ Overview page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1